The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stephan Dietrich A since 2021.
This trader's CIK number is 1774588.
At the time of last reporting, Stephan Dietrich A was the Founder and CEO of Neubase Therapeutics, Inc.. (stock ticker symbol NBSE).
Also see all insider trading activities at Neubase Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NBSE | 0 | $0 | 0 | $0 | 748,234 | $2,051 |
| 2022 | NBSE | 0 | $0 | 0 | $0 | 792,250 | $792 |
| 2021 | NBSE | 12,000 | $60,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-02 | NBSE | Option Ex | 93,234 | .02 | 2,051 |
| 2023-02-13 | NBSE | Option Ex | 655,000 | .00 | 0 |
| 2022-09-28 | NBSE | Option Ex | 750,000 | .00 | 750 |
| 2021-12-31 | NBSE | Option Ex | 42,250 | .00 | 42 |
| 2021-04-26 | NBSE | Buy | 12,000 | 5.00 | 60,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stephan Dietrich A (Founder and CEO of Neubase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.